Skip to main content
. Author manuscript; available in PMC: 2020 Dec 1.
Published in final edited form as: Cancer Res. 2020 Mar 9;80(11):2075–2082. doi: 10.1158/0008-5472.CAN-19-3066

Table 1.

Association of HMGB proteins with cancer outcome.

Protein Cancer outcome DNA damage processing modulation Ref.
HMGB1 • Gastric cancer
• Hepatocellular cancer
• HNSCC
• Nasopharyngeal cancer
• Colorectal cancer
• ESCC
• Mesothelioma
• Bladder cancer
• Prostate cancer
• Cervical cancer
• Ovarian cancer
• NSCLC
• Promotes error-free repair via NER
• Binds with high affinity to chemotherapeutic DNA lesions
• Positive cooperative binding with NER damage recognition proteins on DNA lesions
• Assists in recruitment of XPA to damaged DNA
• Introduces negative supercoiling preferentially to damaged DNA
• HMGB1 depletion increases sensitivity to DNA crosslinking agents
• HMGB1 depletion results in increased DSBs
2731

5464

84105
HMGB2 • HNSCC
• Breast cancer
• Colorectal cancer
• Ovarian cancer
• Gastric cancer
• Increases γ-H2AX foci formation after damage, and delays repair 3338
HMGB3 • Ovarian cancer
• NSCLC
• Colorectal cancer
• Gastric cancer
• ESCC
• Urinary bladder cancer
• HMGB3 depletion downregulates the ATR/CHK1 signaling pathway 3946

HNSCC = Head and neck squamous cell carcinoma, NSCLC = Non-small cell lung cancer, ESCC = Esophageal squamous cell carcinoma